Effect of intravitreal injection of aflibercept on cardiovascular risk parameters in patients with neovascular age related macular degeneration.

CONCLUSIONS: According to our study, administration of a single dose of aflibercept in eyes with neovascular age-related macular degeneration does not seem to affect the evaluated biomarkers that are related to cardiovascular disease.
PMID: 33069198 [PubMed - as supplied by publisher]

Source: Current Clinical Pharmacology - October 16, 2020 Category: Drugs & Pharmacology Authors: Georgakopoulos CD, Pallikari A, Plotas P, Kagkelaris K, Mastronikolis S, Plota M, Emmanuil A, Makri OE Tags: Curr Clin Pharmacol Source Type: research